Recombinant multi-species RAB10 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RAB10 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
RAB10 belongs to the RAS (see HRAS; MIM 190020) superfamily of small GTPases. RAB proteins localize to exocytic and endocytic compartments and regulate intracellular vesicle trafficking (Bao et al., 1998 [PubMed 9918381]).[supplied by OMIM, Mar 2009]
The Alternative Names of target: Ac1075,RAB10,Rab10,Ras-related protein Rab-10

Target products collectionGo to RAB10 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP3845-Ag-1/ GM-Tg-hg-IP3845-Ag-2 Human RAB10 protein Human
GM-Tg-rg-IP3845-Ag-1/ GM-Tg-rg-IP3845-Ag-2 Rat RAB10 protein Rat
GM-Tg-mg-IP3845-Ag-1/ GM-Tg-mg-IP3845-Ag-2 Mouse RAB10 protein Mouse
GM-Tg-cynog-IP3845-Ag-1/ GM-Tg-cynog-IP3845-Ag-2 Cynomolgus/Rhesus macaque RAB10 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP3845-Ag-1/ GM-Tg-felg-IP3845-Ag-2 Feline RAB10 protein Feline
GM-Tg-cang-IP3845-Ag-1/ GM-Tg-cang-IP3845-Ag-2 Canine RAB10 protein Canine
GM-Tg-bovg-IP3845-Ag-1/ GM-Tg-bovg-IP3845-Ag-2 Bovine RAB10 protein Bovine
GM-Tg-equg-IP3845-Ag-1/ GM-Tg-equg-IP3845-Ag-2 Equine RAB10 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP3845-Ag-1/ GM-Tg-hg-IP3845-Ag-2; GM-Tg-rg-IP3845-Ag-1/ GM-Tg-rg-IP3845-Ag-2;
GM-Tg-mg-IP3845-Ag-1/ GM-Tg-mg-IP3845-Ag-2; GM-Tg-cynog-IP3845-Ag-1/ GM-Tg-cynog-IP3845-Ag-2;
GM-Tg-felg-IP3845-Ag-1/ GM-Tg-felg-IP3845-Ag-2; GM-Tg-cang-IP3845-Ag-1/ GM-Tg-cang-IP3845-Ag-2;
GM-Tg-bovg-IP3845-Ag-1/ GM-Tg-bovg-IP3845-Ag-2; GM-Tg-equg-IP3845-Ag-1/ GM-Tg-equg-IP3845-Ag-2
Products Name RAB10 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name RAB10
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RAB10 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.